Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA approves Procainamide HCL Injection, USP for treatment of ventricular arrhythmias

biospectrumasiaOctober 30, 2017

Tag: Procainamide HCL Injection , USP , FDA

PharmaSources Customer Service